Thursday, 22 Jan 2026
Subscribe
logo
  • Global
  • AI
  • Cloud Computing
  • Edge Computing
  • Security
  • Investment
  • Sustainability
  • More
    • Colocation
    • Quantum Computing
    • Regulation & Policy
    • Infrastructure
    • Power & Cooling
    • Design
    • Innovations
    • Blog
Font ResizerAa
Data Center NewsData Center News
Search
  • Global
  • AI
  • Cloud Computing
  • Edge Computing
  • Security
  • Investment
  • Sustainability
  • More
    • Colocation
    • Quantum Computing
    • Regulation & Policy
    • Infrastructure
    • Power & Cooling
    • Design
    • Innovations
    • Blog
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Data Center News > Blog > Investments > Persist AI Raises $12M in Series A Funding
Investments

Persist AI Raises $12M in Series A Funding

Last updated: May 19, 2025 8:02 pm
Published May 19, 2025
Share
Persist AI Raises $12M in Series A Funding
SHARE

Persist AI, a Sacramento, CA-based pioneer in AI-driven robotics for pharmaceutical formulation growth and Chemistry, Manufacturing, and Controls (CMC), closed a $12m Collection A financing spherical.

The spherical was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by International Mind Company, Eli Lilly & Firm, SignalFire, Ford Road Capital, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures, and present traders 2048 Ventures, Innospark, and YCombinator.

The corporate intends to make use of the funds to increase the robotic lab and construct complete knowledge units that prepare its AI fashions, and increase the capability and vary of formulations the AI fashions and robotic lab can predict, construct, and check.

Led by Karthik Raman, CEO, Christopher Shelner, Chief Working Officer, Persist AI leverages predictive AI fashions with automated robotic programs to allow pharmaceutical corporations to develop drug formulations utilizing robotic laboratory amenities by way of an internet site.

As soon as the AI fashions predict a set of formulations, its Cloud Lab permits pharmaceutical scientists to check the formulation by remotely controlling the robotic lab with a mixture of miniaturization and automation of testing devices.

By means of the newly launched Cloud Lab, pharmaceutical corporations worldwide can now remotely construct and check formulations on Persist’s superior robotic amenities to develop:

  • Lengthy performing injectables
  • Tablets and capsules
  • Topical formulations for cosmetics and prescribed drugs
  • Injectable formulations

The platform helps a variety of modalities together with peptides, small molecules, antibodies, and anti-sense oligonucleotides, at present serving a number of high 10 pharmaceutical shoppers and several other smaller biotechs creating next-generation remedies for continual illnesses.

See also  Archon Biosciences Raises $20M in Seed Funding

Persist AI, a Y Combinator-backed startup, having graduated from the accelerator in 2023, will construct a GMP manufacturing system for lengthy performing injectables, in collaboration with Nivagen Prescribed drugs in Sacramento, CA. 

FinSMEs

19/05/2025

Source link

TAGGED: 12m, Funding, persist, Raises, Series
Share This Article
Twitter Email Copy Link Print
Previous Article NVIDIA Unveils RTX PRO Servers to Power Enterprise AI Data Centers NVIDIA Unveils RTX PRO Servers to Power Enterprise AI Data Centers
Next Article Partnership Targets Quantum-Accelerated AI Factories Partnership Targets Quantum-Accelerated AI Factories
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
TwitterFollow
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow
- Advertisement -
Ad image

Popular Posts

QbDVision Raises $13M in Financing

QbDVision, Inc., an Austin, TX-based Digital CMC platform (Chemistry, Manufacturing, and Controls) for the life…

May 4, 2025

Taiwan to build AI supercomputer with help from NVIDIA

Taiwan is planning to construct a large-scale AI supercomputer as a part of a collaboration…

May 20, 2025

The EQUALITY project: Advancing towards quantum algorithms

Quantum computing is among the frontiers of analysis and innovation on account of its potential…

July 25, 2024

Zettabyte Receives Strategic Investment from Lam Capital 

Zettabyte, a Taipei, Taiwan-based AI information heart infrastructure software program firm, acquired a strategic funding…

August 3, 2025

UK and OpenAI pen landmark deal to boost AI adoption

A brand new settlement between the UK’s Ministry of Justice and OpenAI is ready to…

October 25, 2025

You Might Also Like

Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews
AI

Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews

By saad
IO River raises $20M to unbundle the edge and challenge CDN lock-in
Edge Computing

IO River raises $20M to unbundle the edge and challenge CDN lock-in

By saad
Malaysia AI investment takes 32% of Southeast Asia funding
AI

Malaysia AI investment takes 32% of Southeast Asia funding

By saad

OpenHands Raises $18.8M to Scale Enterprise Cloud Coding Agents

By saad
Data Center News
Facebook Twitter Youtube Instagram Linkedin

About US

Data Center News: Stay informed on the pulse of data centers. Latest updates, tech trends, and industry insights—all in one place. Elevate your data infrastructure knowledge.

Top Categories
  • Global Market
  • Infrastructure
  • Innovations
  • Investments
Usefull Links
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2024 – datacenternews.tech – All rights reserved

Welcome Back!

Sign in to your account

Lost your password?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
You can revoke your consent any time using the Revoke consent button.